Diabetes drugs like Ozempic and Mounjaro are being tested to treat behavioral issues and addiction.

I break down the science on how these drugs work, how they affect the brain, and how they could change psychiatry forever.

0:00 Diabetes drugs for other conditions
0:30 GLP-1 and the brain
1:02 How GLP-1 changes behavior
2:56 Potential side effects

I’m Daniela Hernandez, a health and science reporter for WSJ, and on this channel I’ll be covering a variety of subjects from neuroscience to the science of food and public health. If you’re interested in science and health and how cutting edge research impacts our lives, don’t forget to subscribe.

#Ozempic #Addiction #WSJ

свернуть